Figure 2From: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?Kaplan-Meier curves of colon cancer incidence (in accordance with the time of diagnosis) for the study groups (bezafibrate vs. placebo; 6.2 years mean follow-up, p log-rank = 0.07).Back to article page